Charles River Laboratories International, Inc. (CRL)

NYSE · Healthcare · Diagnostics & Research
$314.32-4.15%As of 2026-11-22 · USD
Last session low $310.52Last session high $327.23
52-week low $146.2052-week high $379.63
Market cap
$15.06B
Sector
Healthcare
P/E (TTM)
over 200x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)43.1In the neutral range (30 to 70)
MACD (12, 26, 9)2.07Below its signal line (6.54); histogram -4.47
Bollinger %B (20, 2)7%Inside the bands (309.88 to 375.95)
SMA 20342.91Price is 8.3% below
SMA 50315.98Price is 0.5% below
SMA 200230.81Price is 36.2% above
ATR (20)4.71% of priceAverage true range per day
52-week position72%In the upper part of the 146.20 to 379.63 range

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers.

Insider filings, 90 days1 purchase (about $3K) and 4 sales (about $19.5M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.02B and an operating margin of 10.0%.

More in Diagnostics & Research